Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

Cantor Fitzgerald began coverage on shares of Summit Therapeutics (NASDAQ ... and societal friendly medicinal therapies in the United States, and the United Kingdom. The company’s lead ...

Shares of Revance Therapeutics, Inc. (NASDAQ ... for various aesthetic and therapeutic indications in the United States and internationally. The company’s lead drug candidate is DAXXIFY ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

HADDONFIELD, N.J., March 20, 2025 /PRNewswire/ -- Linnaeus Therapeutics, Inc. (“Linnaeus”), a privately held biopharmaceutical company focused on the development and commercialization of novel, small ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...

With over 2,000 full-time federal employees, the RTP office is the largest EPA facility in the country. Congresswomen Deborah Ross (NC-02) and Valerie Foushee (NC-04), both ranking members of the U.S.

Northumberland National Park has renamed one of its walking trails after a local hero in Newcastle United's Carabao Cup win. Elsdon Burn Walk has been temporarily renamed Big Dan Burn Walk ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best healthcare stocks for long-term investment. In the US, healthcare ...